Hemorrhoid

Global Gastrointestinal Partnering Directory 2014-2021: Trends, Players and Financials for 450+ Deals - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 4, 2022
Medical Devices, Health, Constipation, Peptic ulcer disease, Players, Coeliac disease, Appendicitis, Ulcerative colitis, Irritation, A-Z, Contract, Gastroesophageal reflux disease, Abdominal pain, Gastritis, Irritable bowel syndrome, Finance, Hyperlink, Inflammatory bowel disease, Gastrointestinal disease, Crohn's disease, Technology, Diarrhea, Bottled water, Hernia, Malabsorption, Gastroenteritis, Esophagitis, Ascites, Hemorrhoid, Malnutrition, Pancreatitis, Jaundice

The "Global Gastrointestinal Partnering 2014-2021: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Gastrointestinal Partnering 2014-2021: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering.
  • The Global Gastrointestinal Partnering 2014-2021 report provides comprehensive access to available deals and contract documents for over 450 gastrointestinal deals.
  • The report takes readers through the comprehensive Gastrointestinal disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Gastrointestinal deals.
  • In addition, a comprehensive appendix is provided with each report of all Gastrointestinal partnering deals signed and announced since 2014.

Broadway Vascular Announces Top-Line Results of 12-Month Retrospective Analysis Evaluating Revascularization of the Lateral Plantar Artery in Diabetic Neuropathy

Retrieved on: 
Friday, October 22, 2021
Diabetic neuropathy, Depression, Peripheral neuropathy, Kidney, Quality of life, Peripheral nervous system, Interstate 410, Hemorrhoid, SAN, Interstate Highway System, Prostate, Anxiety, Moyamoya disease, Person, Amputation, Patient, Nerve, Fibroid, Smoking, Hair loss, Disease, Glycated hemoglobin, Hypoesthesia, Diabetes, Atherectomy, Pain, Temperature, Bleeding, GLOBE, Pharmaceutical industry, Medical imaging

SAN ANTONIO, Oct. 22, 2021 (GLOBE NEWSWIRE) -- Broadway Vascular today announced top-line data from a retrospective analysis of Dr. Broadway's revolutionary revascularization technique, involving treating of the lateral plantar artery for treatment of diabetic neuropathy.

Key Points: 
  • SAN ANTONIO, Oct. 22, 2021 (GLOBE NEWSWIRE) -- Broadway Vascular today announced top-line data from a retrospective analysis of Dr. Broadway's revolutionary revascularization technique, involving treating of the lateral plantar artery for treatment of diabetic neuropathy.
  • Dr. Broadway hypothesized that revascularization of the lateral plantar artery will result in regrowth of the nerve fibers, restoring sensation, therefore, treating diabetic neuropathy.
  • The intervention included revascularization of the lateral plantar artery using an atherectomy device with balloon angioplasty.
  • This retrospective study suggests the potential value of revascularization of the lateral plantar artery for treating diabetic neuropathy.

Speer Laboratories, Maker of Emuaid® Products, Ranks #18 On 2021's 50 Fastest Growing Women-Owned/Led Companies

Retrieved on: 
Thursday, October 21, 2021
Woman, Infection, Hemorrhoid, Red, Organization, Laboratory, FDA, Itch, WPO, Award, Dermatitis, JPMorgan Chase, Inflammation, Skin, Irritation, Multimedia, COO, Pain, Wound healing, Burns, Drug, Pharmaceutical industry, Petroleum jelly

The Women Presidents' Organization (WPO), in collaboration with JPMorgan Chase Commercial Banking, released the 14th annual ranking of the 50 Fastest Growing Women-Owned/Led Companies on October 5th.

Key Points: 
  • The Women Presidents' Organization (WPO), in collaboration with JPMorgan Chase Commercial Banking, released the 14th annual ranking of the 50 Fastest Growing Women-Owned/Led Companies on October 5th.
  • The companies on this year's 50 Fastest list span a range of industries, from consumer products to STEM-related fields.
  • From January to December of 2020, the 50 Fastest generated a combined $4.1 billion in revenue and collectively employed more than 24,000 people.
  • Speer Laboratories, led by President and COO, Amy Nicolo, accepted the award at the Awards Reception in Nashville, TN.

Broadway Vascular Opens New Vascular Clinic in San Antonio

Retrieved on: 
Tuesday, October 19, 2021
Pain, Life, Prostate, Artery, Technology, Smoking, Person, Peripheral neuropathy, Blanco River (Texas), Kidney, Diabetes, SAN, Interstate Highway System, Hemorrhoid, Knee pain, Fibroid, Quality of life, Interstate 410, GLOBE, Hair loss, Patient, Health, Blanco, Personal autonomy, Moyamoya disease, Conditional sentence, Broadway, Bleeding, Obesity, Solution, Hotel manager, Dentistry, Medical imaging

SAN ANTONIO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Broadway Vascular is the new vascular specialist in San Antoniofocused on minimally invasive, non-surgical procedures to keep patients out of the hospital.

Key Points: 
  • SAN ANTONIO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Broadway Vascular is the new vascular specialist in San Antoniofocused on minimally invasive, non-surgical procedures to keep patients out of the hospital.
  • Broadway Vascular is operated by Dallas Broadway, MD, who brings years of experience from New York City.
  • Dr. Broadway is not new to San Antonio and has been serving the community for over twoyears.
  • This means at Broadway Vascular, patients have minimal to no pain when a procedure is performed.

Worldwide Embolotherapy Industry to 2026 - Increasing Demand for Minimally Invasive Procedures is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 6, 2021
Surgery, Health, Other Health, Mortality, PG, Gastrointestinal bleeding, Hemorrhoid, Cook Group, Prostatic artery embolization, Patient, Embolization, Disease, Stryker Corporation, PMDA, Microparticle, Growth, Gel, Hepatocellular carcinoma, Boston Scientific, Johnson & Johnson, Transplant, History, Medtronic, Time, Bleeding, CE marking, Industry, Medical imaging

Minimally invasive procedures are considered to be safe, and they are associated with reduced morbidity and mortality.

Key Points: 
  • Minimally invasive procedures are considered to be safe, and they are associated with reduced morbidity and mortality.
  • Due to these reasons, there has been increased demand for minimally invasive procedures such as embolization.
  • Also, it has been observed that with technological advancements, there has been growth in the embolic agents and their usage.
  • Procedures such as prostate artery embolization, bariatric embolization, embolization of hemorrhoids and others have also gained importance over time.

Biomerica Launches New Website For Its EZ Detect™ Colorectal Disease Screening Test

Retrieved on: 
Thursday, August 5, 2021
Company, Diverticulitis, Chief executive officer, Woman, Man, Diet, Blood, Product, Hemorrhoid, Cancer, Pharmacy, Patent, Private Securities Litigation Reform Act, Large intestine, Physician, Bloating, Biomedical technology, EZ, Colorectal cancer, Health, Patient, CPT, COVID-19, Water, IBS, Pain, Polyp, Sale, Diarrhea, Colitis, Food and Drug Administration, Social media, Awareness, Constipation, Fissure, Death, Hospital, EUA, Environment, Nasdaq, Egg, GLOBE, Pharmaceutical industry

IRVINE, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced the launch of their new website for their EZ Detect Colon Disease Test product at https://ezdetect.com .

Key Points: 
  • IRVINE, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced the launch of their new website for their EZ Detect Colon Disease Test product at https://ezdetect.com .
  • [1]
    The EZ Detect Colon Disease Test is the simplest in-home, two-minute diagnostic test to detect hidden blood in the stool, one of the primary early warning signs of colorectal disease.
  • Published studies have also indicated that the best colorectal screening test is the one that gets done.
  • We are extremely excited to announce the launch of our new EZ Detect Colon Test website, commented Zack Irani, CEO of Biomerica.

WELL's CRH Medical Acquires Majority Stake in Greater Washington Anesthesia

Retrieved on: 
Tuesday, August 3, 2021
Outpatient surgery, Surgery, Endoscopy, Rubber band ligation

WELL owns and operates Canada's largest network of outpatient medical clinics serving primary and specialized healthcare services and is the provider of a leading multi-national multi-disciplinary telehealth offering.

Key Points: 
  • WELL owns and operates Canada's largest network of outpatient medical clinics serving primary and specialized healthcare services and is the provider of a leading multi-national multi-disciplinary telehealth offering.
  • In 2014, CRH became a full-service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers.
  • To date, CRH has completed 37 anesthesia acquisitions, and now serves 77 ambulatory surgery centers in 16 states.
  • In addition, CRH owns the "CRH O'Regan System", a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids.

WELL's CRH Medical Announces Acquisition of New England Anesthesia Associates

Retrieved on: 
Monday, May 10, 2021
Clinical medicine, Medicine, Medical specialties, Colorectal surgery, Surgery, Banding, Endoscopy, Hemorrhoid, Rubber band ligation

WELL\'s wholly owned subsidiary CRH Medical is a leading provider of anesthesia services and the patented O\'Regan hemorrhoid banding product to gastrointestinal focused clinics.

Key Points: 
  • WELL\'s wholly owned subsidiary CRH Medical is a leading provider of anesthesia services and the patented O\'Regan hemorrhoid banding product to gastrointestinal focused clinics.
  • In 2014, CRH became a full service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers.
  • To date, CRH has completed 34 anesthesia acquisitions, and now serves 73 ambulatory surgical centers in 16 states.
  • In addition, CRH owns the "CRH O\'Regan System", a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids.

WELL Health Reports on CRH Medical's Upsized US$300M Revolving Credit Facility with JP Morgan

Retrieved on: 
Monday, April 26, 2021
Clinical medicine, Medicine, Medical specialties, Diagnostic gastroenterology, Colorectal surgery, Chromium(I) hydride, Endoscopy, Hemorrhoid, Surgery, Banding, Rubber band ligation

WELL is also a provider of digital health, billing and cybersecurity related technology solutions.

Key Points: 
  • WELL is also a provider of digital health, billing and cybersecurity related technology solutions.
  • In 2014, CRH became a full service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers.
  • In addition, CRH owns the "CRH O\'Regan System", a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids.
  • Except as required by law, the Company does not intend to update these forward-looking statements.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/well-health-reports-on-crh-medic...\nSOURCE WELL Health Technologies Corp.\n'

WELL Health Provides an Update on its Proposed Acquisition of CRH Medical

Retrieved on: 
Monday, April 19, 2021
Medical specialties, Clinical medicine, Medicine, Colorectal surgery, Surgery, Hemorrhoid, Endoscopy, Rubber band ligation

WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL".

Key Points: 
  • WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL".
  • In 2014, CRH became a full service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers.
  • To date, CRH has completed 33 anesthesia acquisitions, and now serves 72 ambulatory surgical centers in 15 states.
  • In addition, CRH owns the "CRH O\'Regan System", a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids.